The most compelling near term applications (NITP etc) use fragmented DNA, and long reads will have no benefit here.
So, yes. Long reads are useful, but you need to have at least reasonable performance in other respects. The same thing has been seen with PacBio, who have not played well in the market, despite having a read length advantage.